Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population

Objective: To describe the baseline characteristics of the participants in the Three-City (3C) Study, a study aiming to evaluate the risk of dementia and cognitive impairment attributable to vascular factors. Methods: Between 1999 and 2001, 9,693 persons aged 65 years and over, noninstitutionalized, were recruited from the electoral rolls of three French cities, i.e. Bordeaux, Dijon and Montpellier. Health-related data were collected during face-to-face interviews using standardized questionnaires. The baseline examination included cognitive testing and diagnosis of dementia, and assessment of vascular risk factors, including blood pressure measurements, ultrasound examination of the carotid arteries, and measurement of biological parameters (glycemia, total, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, creatinemia); 3,442 magnetic resonance imaging (MRI) examinations were performed in subjects aged 65–79. Measurements of ultrasound, blood, and MRI parameters were centralized. Two follow-up examinations (at 2 and 4 years) were planned. Results: After exclusion of the participants who had subsequently refused the medical interview, the 3C Study sample consisted of 3,649 men (39.3%) and 5,645 women, mean age 74.4 years, with a relatively high level of education and income. Forty-two percent of the participants reported to be followed up for hypertension, about one third for hypercholesterolemia, and 8% for diabetes; 65% had elevated blood pressure measures (systolic blood pressure ≧140 or diastolic blood pressure ≧90). The proportion of Mini-Mental State Examination scores below 24 was 7% and dementia was diagnosed in 2.2% of the participants. Conclusion: Distribution of baseline characteristics of the 3C Study participants suggests that this study will provide a unique opportunity to estimate the risk of dementia attributable to vascular factors.

[1]  W. Rocca,et al.  Prevalence of Parkinson's disease and other types of parkinsonism , 1992, Neurology.

[2]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[3]  Robert D. Harris,et al.  Vascular , 1993 .

[4]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[5]  John J. Fortman,et al.  Variations on the , 1999 .

[6]  M. Tinetti Performance‐Oriented Assessment of Mobility Problems in Elderly Patients , 1986, Journal of the American Geriatrics Society.

[7]  Neil Chapman,et al.  Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.

[8]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[9]  V. Hachinski Vascular dementia: a radical redefinition. , 1994, Dementia.

[10]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[11]  C. Dufouil,et al.  Cognitive decline in individuals with high blood pressure , 1999, Neurology.

[12]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[13]  C. Schweiger [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[14]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[15]  C. Dufouil,et al.  Influence of education on the relationship between white matter lesions and cognition , 2003, Neurology.

[16]  D. Commenges,et al.  Improving screening for dementia in the elderly using, Mini-Mental State Examination subscores, Benton's Visual Retention Test, and Isaacs' Set Test. , 1992, Epidemiology.

[17]  D. Calne,et al.  Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity , 1995, Movement disorders : official journal of the Movement Disorder Society.

[18]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[19]  A. Alpérovitch,et al.  Bias in association studies resulting from gene-environment interactions and competing risks. , 2002, American journal of epidemiology.

[20]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[21]  C. Counsell,et al.  Assessment of clinical outcomes in acute stroke trials. , 1998, Stroke.

[22]  L. Radloff The CES-D Scale , 1977 .

[23]  C. Dufouil,et al.  Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging. , 1997, American journal of epidemiology.

[24]  Kenneth Rockwood,et al.  Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. , 2002, Archives of neurology.

[25]  A. Romelsjö,et al.  Association between alcohol consumption and mortality, myocardial infarction, and stroke in 25 year follow up of 49 618 young Swedish men , 1999, BMJ.

[26]  I. Rosow,et al.  A Guttman health scale for the aged. , 1966, Journal of gerontology.

[27]  Lawton Mp Scales to measure competence in everyday activities. , 1988 .

[28]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[29]  B Isaacs,et al.  The Set Test as an Aid to the Detection of Dementia in Old People , 1973, British Journal of Psychiatry.

[30]  V Hachinski,et al.  Vascular Factors in Cognitive Impairment‐Where Are We Now? , 2000, Annals of the New York Academy of Sciences.

[31]  P. Heuschmann,et al.  Variations in Stroke Incidence and Survival in 3 Areas of Europe , 2000, Stroke.

[32]  L. Ferrucci,et al.  Mild cognitive impairment: Clinical features and review of screening instruments , 2001, Aging.

[33]  O. Spreen,et al.  Predicting premorbid IQ: A revision of the national adult reading test , 1989 .

[34]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[35]  F. Pasquier,et al.  Frontotemporal Behavioral Scale , 1998, Alzheimer disease and associated disorders.

[36]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[37]  R. Sacco,et al.  The protective effect of moderate alcohol consumption on ischemic stroke. , 1999, JAMA.

[38]  D Commenges,et al.  A cognitive screening battery for dementia in the elderly. , 2000, Journal of clinical epidemiology.

[39]  M P Lawton,et al.  Scales to measure competence in everyday activities. , 1988, Psychopharmacology bulletin.

[40]  P Ducimetière,et al.  Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.